ISRCTN18159776
Active, not recruiting
未知
Application of enamel matrix derivate, deproteinized bovine bone and collagen membrane for the reconstructive treatment of periimplant intrabony defect: a randomized clinical trial
ThinkingPerio Research0 sites40 target enrollmentApril 15, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Intraosseous peri-implant defects
- Sponsor
- ThinkingPerio Research
- Enrollment
- 40
- Status
- Active, not recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients that show radiographically peri\-implant intraosseous defects of at least 3 mm depth
- •2\. Depth of clinical probing \=5 mm with bleeding and/or suppuration
- •3\. Intra\-surgically, the infra\-osseous defect must have at least one intraosseous component of 3 mm and a width of no more than 4 mm
- •4\. The implant to be treated must have been in function for at least 12 months
Exclusion Criteria
- •1\. Patients with diabetes mellitus, hyperparathyroidism and/or osteomalacia
- •2\. Patients treated with corticosteroids
- •3\. Patients medicated with drugs that induce gingival hyperplasia
- •4\. Allergic to penicillin or who have taken antibiotics in the last 6 months
- •5\. Pregnant or breastfeeding patients
- •6\. Patients with osteoporosis
- •7\. Impossibility of stabilizing bovine bone with collagen or primary closure of soft tissue
- •8\. Patients with collagen allergy
- •9\. Patients treated with radiotherapy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Adjunctive use of enamel matrix derivatives to porcine derived xenograft for the treatment of one-wall intrabony defects: two-year longitudinal results of a randomized controlled clinical trialKCT0004164Wonkwang University Daejeon Dental Hospital50
Completed
Not Applicable
Can the results of non-surgical therapy of periodontitis be improved by the use of enamel matrix proteins?ISRCTN14654696niversity of Bonn44
Completed
Phase 4
The effect of Emdogain on changes in cytokine profile during early wound healingISRCTN13262303Regional Committees for Medical and Health Research Ethics (REK)15
Completed
Phase 4
EMD and/or Bone Substitute for the Treatment of Class II FurcationsPeriodontal DiseaseNCT02474498University of Campinas, Brazil41
Not yet recruiting
Not Applicable
Enamel matrix derivative (EMD) applied in non-surgical periodontal treatment: A randomized, controlled clinical trialNot ApplicableKCT0007436Yonsei University Health System, Dental Hospital60